Cargando…
Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS
In the current World Health Organization (WHO)-classification, therapy-related myelodysplastic syndromes (t-MDS) are categorized together with therapy-related acute myeloid leukemia (AML) and t-myelodysplastic/myeloproliferative neoplasms into one subgroup independent of morphologic or prognostic fe...
Ejemplares similares
-
Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis
por: Kuendgen, A, et al.
Publicado: (2013) -
TET2 missense variants in human neoplasia. A proposal of structural and functional classification
por: Bussaglia, Elena, et al.
Publicado: (2019) -
Serological classification of spiroplasmas: current status.
por: Whitcomb, R. F., et al.
Publicado: (1983) -
Classification of Andrographis paniculata extracts by solvent extraction using HPLC fingerprint and chemometric analysis
por: Rafi, M., et al.
Publicado: (2020) -
Classification of primary and incisional abdominal wall hernias
por: Muysoms, F. E., et al.
Publicado: (2009)